The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lúdvíksson, B. R.
Right arrow Articles by Ehrhardt, R. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lúdvíksson, B. R.
Right arrow Articles by Ehrhardt, R. O.
The Journal of Immunology, 1999, 162: 4975-4982.
Copyright © 1999 by The American Association of Immunologists

Administration of mAb Against {alpha}Eß7 Prevents and Ameliorates Immunization-Induced Colitis in IL-2-/- Mice

Björn R. Lúdvíksson1,*, Warren Strober*, Ryuta Nishikomori*, Syed K. Hasan* and Rolf O. Ehrhardt*,{dagger}

* Mucosal Immunity Section, Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, and {dagger} Protein Design Laboratories, Inc., Mountain View, CA 94043

We previously demonstrated that 2,4,6-trinitrophenol (TNP)-OVA immunization leads to a transmural colitis in the IL-2-/- mouse that is caused by IL-12-driven CD4+ Th1 T cells and resembles human Crohn’s disease. The integrin {alpha}Eß7 is highly expressed on colonic intraepithelial lymphocytes and has been suggested to function as a homing or retention molecule for intraepithelial lymphocytes. To evaluate the role of {alpha}Eß7 in colitis, we administered a mAb against {alpha}Eß7 to IL-2-/- mice that were immunized at the same time with TNP-OVA in CFA. To our surprise, this treatment resulted in a significantly reduced colitis severity score, 0–2 vs 3–4, that was associated with a significant reduction in CD4+ lamina propria lymphocyte subpopulation (p < 0.01). In contrast, the total number of splenic CD4+ T cells of treated animals was significantly elevated compared with that of untreated animals (3.2 ± 0.6 x 107 vs 1.2 ± 0.2 x 107; p < 0.05). Similarly, functional studies revealed that IFN-{gamma} production by lamina propria lymphocytes isolated from IL-2-/- TNP-OVA-immunized mice treated with anti-{alpha}Eß7 was significantly lower than in untreated IL-2-/- TNP-OVA-immunized mice. In contrast, IFN-{gamma} production by splenic cells isolated from treated IL-2-/- TNP-OVA-immunized mice was significantly higher than in untreated mice. Finally, TNP-OVA-immunized IL-2-/- mice that were treated after the colitis had been established also showed a significant decrease in mucosal inflammation after {alpha}Eß7 mAb administration. Thus, the above findings demonstrate that the onset and maintenance of inflammatory bowel disease depends on the colonic localization of lamina propria CD4+ lymphocytes expressing {alpha}Eß7.




This article has been cited by other articles:


Home page
 JEMHome page
J. Rivera-Nieves, T. L. Burcin, T. S. Olson, M. A. Morris, M. McDuffie, F. Cominelli, and K. Ley
Critical role of endothelial P-selectin glycoprotein ligand 1 in chronic murine ileitis
J. Exp. Med., April 17, 2006; 203(4): 907 - 917.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. Waldman, S. X. Lu, V. M. Hubbard, A. A. Kochman, J. M. Eng, T. H. Terwey, S. J. Muriglan, T. D. Kim, G. Heller, G. F. Murphy, et al.
Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine
Blood, February 15, 2006; 107(4): 1703 - 1711.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
O. Annacker, J. L. Coombes, V. Malmstrom, H. H. Uhlig, T. Bourne, B. Johansson-Lindbom, W. W. Agace, C. M. Parker, and F. Powrie
Essential role for CD103 in the T cell-mediated regulation of experimental colitis
J. Exp. Med., October 17, 2005; 202(8): 1051 - 1061.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Refaeli, K. A. Field, B. C. Turner, A. Trumpp, and J. M. Bishop
The protooncogene MYC can break B cell tolerance
PNAS, March 15, 2005; 102(11): 4097 - 4102.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Rivera-Nieves, T. Olson, G. Bamias, A. Bruce, M. Solga, R. F. Knight, S. Hoang, F. Cominelli, and K. Ley
L-Selectin, {alpha}4{beta}1, and {alpha}4{beta}7 Integrins Participate in CD4+ T Cell Recruitment to Chronically Inflamed Small Intestine
J. Immunol., February 15, 2005; 174(4): 2343 - 2352.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
F Bataille, F Klebl, P Rummele, J Schroeder, S Farkas, P-J Wild, A Furst, F Hofstadter, J Scholmerich, H Herfarth, et al.
Morphological characterisation of Crohn's disease fistulae
Gut, September 1, 2004; 53(9): 1314 - 1321.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
J A Kirby, M Bone, H Robertson, M Hudson, and D E J Jones
The number of intraepithelial T cells decreases from ascending colon to rectum
J. Clin. Pathol., February 1, 2003; 56(2): 158 - 158.
[Full Text] [PDF]

Home page
 JEMHome page
P. J. Kilshaw and J. M.G. Higgins
Alpha E: No More Rejection?
J. Exp. Med., October 7, 2002; 196(7): 873 - 875.
[Full Text] [PDF]

Home page
 J. Virol.Home page
L. Stevceva, B. Kelsall, J. Nacsa, M. Moniuszko, Z. Hel, E. Tryniszewska, and G. Franchini
Cervicovaginal Lamina Propria Lymphocytes: Phenotypic Characterization and Their Importance in Cytotoxic T-Lymphocyte Responses to Simian Immunodeficiency Virus SIVmac251
J. Virol., January 1, 2002; 76(1): 9 - 18.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
S. Koseki, S. Miura, H. Fujimori, R. Hokari, S. Komoto, Y. Hara, T. Ogino, H. Nagata, M. Goto, S. Hachimura, et al.
In situ demonstration of intraepithelial lymphocyte adhesion to villus microvessels of the small intestine
Int. Immunol., September 1, 2001; 13(9): 1165 - 1174.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
U. G. Strauch, R. C. Mueller, X. Y. Li, M. Cernadas, J. M. G. Higgins, D. G. Binion, and C. M. Parker
Integrin {{alpha}}E(CD103){{beta}}7 Mediates Adhesion to Intestinal Microvascular Endothelial Cell Lines Via an E-Cadherin-Independent Interaction
J. Immunol., March 1, 2001; 166(5): 3506 - 3514.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
S Sarnacki, F Auber, C Cretolle, C Camby, M Cavazzana-Calvo, W Muller, N Wagner, N Brousse, Y Revillon, A Fischer, et al.
Blockade of the integrin alpha Lbeta 2 but not of integrins alpha 4 and/or beta 7 significantly prolongs intestinal allograft survival in mice
Gut, July 1, 2000; 47(1): 97 - 104.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Chu, K. Hong, E. L. Berg, and R. O. Ehrhardt
Tissue Specificity of E- and P-Selectin Ligands in Th1-Mediated Chronic Inflammation
J. Immunol., November 1, 1999; 163(9): 5086 - 5093.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. M. G. Higgins, M. Cernadas, K. Tan, A. Irie, J.-h. Wang, Y. Takada, and M. B. Brenner
The Role of alpha and beta Chains in Ligand Recognition by beta 7 Integrins
J. Biol. Chem., August 11, 2000; 275(33): 25652 - 25664.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.